Compartir

Acceso a las Pruebas de Biomarcadores Press Releases

22 de Febrero de 2024

State Legislator Honored for Opening Door to Precision Medicine and Targeted Therapies

SANTA FE, NEW MEX. – February 22, 2024 – State Representative Joy Garratt was honored with the ‘Legislative Champion Award’ by the American Cancer Society Cancer Action Network (ACS CAN)  during a luncheon, Thursday. This award is the highest honor given by the organization. Garratt was recognized for her leading role in expanding access to biomarker testing in New Mexico. She served as a lead sponsor for HB 73 during the 2023 legislative session. 

22 de Febrero de 2024

New Paper Finds Barriers to Equitable Discovery and Implementation of Pharmacogenomic Testing in Cancer Care Despite its Power to Improve Patient Outcomes

A new paper released today in the Journal of Clinical Oncology finds that while incorporating pharmacogenomic (PGx) testing into cancer care can help improve patient outcomes, barriers to PGx testing, discovery, and implementation are impacting its adoption and creating disparities that impact diverse populations.


 
6 de Febrero de 2024

Senate Votes to Remove Barriers to Precision Treatments

INDIANAPOLIS, IN – This afternoon, the Indiana Senate passed Senate Bill 273, which would ensure biomarker testing, a game changer in the fight against cancer and an essential step in accessing precision medicine treatments, is covered by more insurance plans in the Hoosier state

5 de Febrero de 2024

Biomarker Testing Bill Fails to Advance

Cancer patients, survivors, their families and caregivers from throughout Washington gathered at the Capitol on Monday to ask legislators to support House Bill 1450, which would have expanded insurance coverage of biomarker testing and made sure as many state residents as possible have access to this technology. They were disappointed to learn that the bill did not advance through House Appropriations and so instead turned their efforts and advocacy to the 2025 session.